Soler-Botija, Carolina <br/><br/>
Implication of fetal SMN2 expression in type I SMA pathogenesis: protection or pathological gain of function?  [electronic resource] 

 -  Journal of neuropathology and experimental neurology  Mar 2005 
 - 215-23 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-3069 
<br/><br/><label>Standard No.: </label>10.1093/jnen/64.3.215  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Alternative Splicing<br/>Blotting, Western--methods<br/>Cyclic AMP Response Element-Binding Protein--genetics<br/>Densitometry--methods<br/>Exons<br/>Female<br/>Fibroblasts--metabolism<br/>Gene Expression--genetics<br/>Gene Expression Regulation, Developmental--genetics<br/>Humans<br/>Immunohistochemistry--methods<br/>Kidney--metabolism<br/>Male<br/>Muscles--cytology<br/>Muscular Atrophy, Spinal--metabolism<br/>Nerve Tissue Proteins--genetics<br/>Pregnancy<br/>RNA, Messenger--biosynthesis<br/>RNA-Binding Proteins--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction--methods<br/>SMN Complex Proteins<br/>Survival of Motor Neuron 1 Protein<br/>Survival of Motor Neuron 2 Protein<br/>alpha-Fetoproteins